AbbVie vs Tata Motors: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Tata Motors was founded in 1945 by J.R.D. Tata, Sumant Moolgaokar and is led by Girish Wagh.
Company facts
AbbVie
- Founded
- 2013
- Headquarters
- North Chicago, Illinois
- Current CEO
- Robert A. Michael
- Employees
- 57,000
Tata Motors
- Founded
- 1945
- Headquarters
- Mumbai, Maharashtra, India
- Current CEO
- Girish Wagh
- Employees
- 40,578
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Tata Motors
J.R.D. Tata
J.R.D. Tata chaired the Tata Group from 1938 to 1991 and founded Tata Engineering and Locomotive Company (TELCO) in 1945 to build locomotives and engineering products.
Sumant Moolgaokar
Sumant Moolgaokar was the engineer who ran TELCO for decades and built its manufacturing base, including the Pune plant and research capability. He is often called the architect of Tata Motors, and the Tata Sumo was named after him.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Tata Motors
- Ratan Tata1991–2012
Former Chairman
He transformed Tata Motors from a domestic truck manufacturer into a globally recognized automotive powerhouse, cementing its presence in the premium luxury sector.
Source - N. Chandrasekaran2017–present
Chairman
As Chairman, he stabilized Jaguar Land Rover's severe cash burn during the semiconductor crisis and secured Tata Motors' absolute dominance in the early Indian EV market.
Source - Girish Wagh2025–present
Managing Director and CEO
Wagh leads the post-demerger company, which reported FY2026 revenue of ~$9.73B (INR83,855 Cr) and Q1 FY2027 wholesales of 108,700 units, and is driving the Iveco acquisition. He previously headed Tata's commercial-vehicle business as an executive director.
Source - G.V. Ramanan2025–present
Chief Financial Officer
He helped maintain Tata's absolute monopoly in the heavy commercial vehicle segment against rising international competition.
Source
Timeline: AbbVie and Tata Motors side by side
1945Tata Motors
TELCO is founded
Tata Engineering and Locomotive Company is established, forming the roots of Tata Motors.
1954Tata Motors
Commercial vehicle production begins
Tata enters commercial-vehicle production through a collaboration with Daimler-Benz.
1954Tata Motors
First Indian-Built Commercial Vehicle
TELCO produces its first commercial vehicle in collaboration with Daimler-Benz, marking India's entry into domestic truck manufacturing.
1998Tata Motors
Tata Indica Launches
Tata Motors launches the Indica, its first indigenously designed passenger car, marking a major expansion beyond commercial vehicles.
2004Tata Motors
Daewoo commercial vehicle business acquired
Tata Motors acquires Daewoo Commercial Vehicle in South Korea, expanding heavy-truck capabilities.
2008Tata Motors
Jaguar Land Rover acquired
Tata Motors acquires Jaguar Land Rover from Ford, transforming old Tata Motors into a global automaker.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023Tata Motors
Sanand plant acquisition completed
Tata Passenger Electric Mobility completes the acquisition of Ford India's Sanand plant.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2024Tata Motors
Ratan Tata Dies
Ratan Tata, the Tata Group chairman who led the transformative Jaguar Land Rover acquisition, dies in October 2024.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Tata Motors
Demerger takes effect
The composite scheme separates commercial vehicles from passenger vehicles and JLR, changing the current Tata Motors Ltd perimeter.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026Tata Motors
FY2026 revenue is reported
Current Tata Motors Limited reports FY2026 consolidated revenue of ~$9.73B (INR83,855 Cr).
2026Tata Motors
Iveco tender offer launched
After Consob approval, Tata Motors launches a EUR14.10-per-share all-cash offer for Iveco Group, open September 7 to October 26, 2026.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Tata Motors
- Iveco Group2026$4.4B
- Ford India Sanand plant2023Undisclosed
- Jaguar Land Rover2008$2.3B
- Daewoo Commercial Vehicle2004Undisclosed
Questions about AbbVie vs Tata Motors
Who is the CEO of AbbVie Inc. and Tata Motors Limited?
AbbVie Inc. is led by Robert A. Michael and Tata Motors Limited is led by Girish Wagh. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Tata Motors Limited?
Tata Motors Limited was founded in 1945 — 68 years before AbbVie Inc., which was founded in 2013. Tata Motors Limited's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Tata Motors Limited?
AbbVie Inc. employs approximately 57,000 people, while Tata Motors Limited employs approximately 40,578. AbbVie Inc. has the larger workforce at 57,000 employees, compared to Tata Motors Limited's 40,578. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Tata Motors Limited headquartered?
AbbVie Inc. is headquartered in United States and Tata Motors Limited is headquartered in India. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded AbbVie Inc. and Tata Motors Limited?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Tata Motors Limited was founded by J.R.D. Tata, Sumant Moolgaokar.
Which company has a longer operating history — AbbVie Inc. or Tata Motors Limited?
Tata Motors Limited has been operating for approximately 81 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Tata Motors overview